Jesse Kesner

Jesse Kesner is the Co-Founder and CEO of Alnu Health, a digital health startup helping patients own their health journeys and sustain outcomes while on GLP-1 therapy. Before launching Alnu, Jesse was an investor at L Catterton and a consultant at McKinsey & Company, where he also spent time on secondment to Peloton’s Strategy team shaping growth initiatives in the post-COVID era. A current MBA candidate at Harvard Business School, Jesse brings a deep passion for combining technology, clinical insight, and behavioral science to make metabolic health more accessible and sustainable.